Hargis A M, Winkelstein J A, Moore M P, Weidner J P, Prieur D J
Department of Veterinary Microbiology and Pathology, Washington State University, Pullman 99164-7040.
Vet Immunol Immunopathol. 1988 Dec;20(1):95-100. doi: 10.1016/0165-2427(88)90029-3.
CH50, C4, C2, and C3 levels were evaluated in 7 dogs affected with dermatomyositis and in 22 control dogs. Dogs with dermatomyositis did not have clinical evidence of active disease at the time of serum collection for complement assays. No absolute complement component deficiency was identified in dermatomyositis-affected dogs in this study; however, a statistical difference in C2 was identified between control dogs of non-collie breeds and control collies, suggesting there may be a breed difference in complement levels.
对7只患有皮肌炎的犬和22只对照犬进行了总补体活性(CH50)、补体C4、C2和C3水平评估。在采集用于补体检测的血清时,患有皮肌炎的犬没有活动性疾病的临床证据。本研究中未在患有皮肌炎的犬中发现绝对补体成分缺乏;然而,在非柯利犬种的对照犬和对照柯利犬之间发现了C2水平的统计学差异,这表明补体水平可能存在品种差异。